PNC-27 is a peptide derived from a segment of the tumor-suppressor protein p53. It has gained attention for its potential anticancer properties by selectively targeting and killing cancer cells without harming normal cells. PNC-27 has been primarily investigated for its ability to induce cell membrane lysis in cancerous cells, leading to their destruction. Research into PNC-27 is ongoing, with early findings suggesting its potential as a novel therapeutic option in cancer treatment.
PNC-27 was developed as part of efforts to explore the anticancer potential of p53, a protein known for its role in regulating cell division and preventing the formation of tumors. The peptide was designed to mimic specific parts of p53, allowing it to bind to cancer cell membranes and induce cell death. Early studies have focused on its ability to target various types of cancer, including leukemia, pancreatic cancer, and breast cancer, while sparing healthy tissue. Although still in the experimental stages, PNC-27 offers promise as a targeted cancer therapy.
SKU: PNC/5/10/SV/KIT
